INVESTOR
RELATIONS
This site uses cookies in order to provide a higher level of service to our customers. For more information on how we use cookies, please see our Privacy Policy. If you agree to the use of cookies, please click “OK”.
OK
IR INFORMATION
IR TOPICS
-
2023.02.10
Financial Reports
Summary of Consolidated Financial Results for the Third Quarter of Fiscal Year Ending March 31, 2023 (Nine Months Ended December 31, 2022）
-
2023.01.26
Timely Disclosure
Announcement of Forecast for Dividend Increase and Commemorative Dividend
-
2023.01.10
Timely Disclosure
Start of Joint Research Using Medical Big Data for Treating Broken Bones
-
2023.01.06
Timely Disclosure
Notice of Establishment of Subsidiary
-
2023.01.05
Timely Disclosure
Notice of New Other Affiliated Company
IR Library
Financial Reports
-
2023.02.10
Summary of Consolidated Financial Results for the Third Quarter of Fiscal Year Ending March 31, 2023 (Nine Months Ended December 31, 2022）
-
2022.11.10
Summary of Consolidated Financial Results for the Second Quarter of Fiscal Year Ending March 31, 2023 (Six Months Ended September 30, 2022)
-
2022.08.10
Summary of Consolidated Financial Results for the First Quarter of Fiscal Year Ending March 31, 2023 (Three Months Ended June 30, 2022)
